Did you know? GLP-1 medications weight regain and stigma
Did you know that emerging evidence indicates that weight regain commonly
occurs after discontinuing GLP-1 medications, although weight generally
remains below pre-treatment levels. This requires careful interpretation, particularly
as the World Health Organization (WHO) recognises obesity as a chronic, relapsing
disease.
Read more in our report Exploring the public health and equalities implications of GLP-1 obesity medications.
Did you know? GLP-1 medications weight regain and stigma
pdf | 1.69MB
Back to